The Pain Management Unit at Quirónsalud Torrevieja Hospital highlights the need to improve healthcare for patients living ...

A new explanation for why some people are in long-term pain says it could be caused by the immune system attacking the person ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Brits have been issued an urgent warning to take care when walking outdoors this summer due to a serious risk to health. The ...

Fibromyalgia can take years to diagnose, and many healthcare providers still lack the tools to confidently identify it. This ...

The FDA rejected Axsome's AXS-14 fibromyalgia, prompting a new trial and pushing the expected drug launch to 2028.

Brits are being urged to exercise caution when walking outdoors this summer due to a significant health risk. The UK Health ...

FDA concluded that AXS-14’s New Drug Application was not sufficiently complete for substantive review, citing concerns with one of two clinical trials in fibromyalgia patients.

Then, clean the bite area with soap and water, and monitor it for a few weeks for "any changes". The health authority warned: ...

Shan critiqued several factors of the study, including use of Patient Global Impression of Change (PGIC) for the primary endpoint, the statistical analysis, the control group selection, and ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...

The Cleveland Clinic recommends that people with POTS consume 3,000 to 10,000 mg of sodium per day to help maintain blood ...